TXNIP and hyperlipidemia: In 2004, studies on HcB-19 mice, a mouse model of hyperlipidemia, showed that mutated TXNIP (Txnip-/-) resulted in increased fatty acid synthesis and cholesterol accumulation, attributing to TXNIP the role of a metabolic regulator [7].